Jaguar Health (JAGX) Stock Price Down 18.2%
Shares of Jaguar Health Inc (NASDAQ:JAGX) traded down 18.2% during trading on Monday . The company traded as low as $0.26 and last traded at $0.27. 12,405,623 shares changed hands during trading, an increase of 194% from the average session volume of 4,220,825 shares. The stock had previously closed at $0.33.
Separately, ValuEngine lowered Jaguar Health from a “buy” rating to a “hold” rating in a report on Thursday, January 24th.
The company has a debt-to-equity ratio of 1.03, a quick ratio of 0.31 and a current ratio of 0.46.
Jaguar Health Company Profile (NASDAQ:JAGX)
Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
See Also: Why Dividend Stocks May Be Right for You
Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.